Evidence map›Paper›PMID 37443383›Full record

ArticleScientific reports2023

Elevated serum leptin is associated with attenuated reward anticipation in major depressive disorder independent of peripheral C-reactive protein levels.

Kaiping Burrows, Breanna A McNaughton, Leandra K Figueroa-Hall, Philip A Spechler, Rayus Kuplicki, Teresa A Victor, Robin Aupperle, Sahib S Khalsa, Jonathan B Savitz, T Kent Teague and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kaiping BurrowsLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA. kburrows@laureateinstitute.org.
Breanna A McNaughtonLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Leandra K Figueroa-HallLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Philip A SpechlerLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.ORCID 0000-0003-3833-7672
Rayus KuplickiLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Teresa A VictorLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Robin AupperleLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.ORCID 0000-0003-2173-6140
Sahib S KhalsaLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Jonathan B SavitzLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.ORCID 0000-0001-8143-182X
T Kent TeagueDepartments of Surgery and Psychiatry, School of Community Medicine, The University of Oklahoma, Tulsa, OK, USA.
Martin P PaulusLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Jennifer L StewartLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.ORCID 0000-0003-0123-9438
Tulsa Community College · USLaureate Institute for Brain Research · USOklahoma State University Center for Health Sciences · US

Funding

The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)P20GM121312 · NIGMS · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI Masaya Misaki · 2017 to 2026
$23.7M
Plasticity of Aversive Salience in Opioid Use DisorderR01DA050677 · NIDA · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI STEWART, JENNIFER LORRAINE · 2021 to 2025
$3.0M
In vivo inflammatory challenge to elucidate the role of the toll-like receptor 4 pathway in depressionK99MH126950 · NIMH · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI FIGUEROA-HALL, LEANDRA KALI · 2022 to 2023
$200k
NIDA NIH HHS R01 DA050677NIGMS NIH HHS P20 GM121312NIMH NIH HHS K99 MH126950NIMH NIH HHS L30 MH131119
6 · The paper itself

Abstract

Major depressive disorder (MDD) is associated with immunologic and metabolic alterations linked to central processing dysfunctions, including attenuated reward processing. This study investigated the associations between inflammation, metabolic hormones (leptin, insulin, adiponectin), and reward-related brain processing in MDD patients with high (MDD-High) and low (MDD-Low) C-reactive protein (CRP) levels compared to healthy comparison subjects (HC). Participants completed a blood draw and a monetary incentive delay task during functional magnetic resonance imaging. Although groups did not differ in insulin or adiponectin concentrations, both MDD-High (Wilcoxon p = 0.004, d = 0.65) and MDD-Low (Wilcoxon p = 0.046, d = 0.53) showed higher leptin concentrations than HC but did not differ from each other. Across MDD participants, higher leptin levels were associated with lower brain activation during reward anticipation in the left insula (r = - 0.30, p = 0.004) and left dorsolateral putamen (r = -- 0.24, p = 0.025). In contrast, within HC, higher leptin concentrations were associated with higher activation during reward anticipation in the same regions (insula: r = 0.40, p = 0.007; putamen: r = 0.37, p = 0.014). Depression may be characterized by elevated pro-inflammatory signaling via leptin concentrations through alternate inflammatory pathways distinct to CRP.

Indexed as

InsulinsMajor Depressive DisorderAdiponectinC-Reactive ProteinHumansLeptinMagnetic Resonance ImagingMotivationRewardAdiponectinC-Reactive ProteinInsulinsLeptin

Identifiers

PMID37443383
PMCPMC10344903
OpenAlexW4384203723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.